Tharimmune, Inc.
Why Robinhood?
You can watch THAR and buy or sell other stocks, ETFs, and their options commission-free!About THAR
Canton Strategic Holdings, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure.
THAR Key Statistics
Stock Snapshot
Tharimmune, Inc.(THAR) stock is priced at $4.74, giving the company a market capitalization of 34.16M. It carries a P/E multiple of -1.15.
On 2026-03-06, Tharimmune, Inc.(THAR) stock opened at —, reached a high of —, and a low of —.
The Tharimmune, Inc.(THAR)'s current trading volume is 0, compared to an average daily volume of 667.96K.
During the past year, Tharimmune, Inc.(THAR) stock moved between $0.95 at its lowest and $9.08 at its peak.
During the past year, Tharimmune, Inc.(THAR) stock moved between $0.95 at its lowest and $9.08 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.